October 2018: OncoMark to attend the European Society of Medical Oncology (ESMO) 2018 Congress
Members of the OncoMark team will be attending the European Society of Medical Oncology 2018 Congress in Munich, Germany, from the 19th- 22nd October. Mr. Des O’Leary (CEO), Mr William Gallagher (Chief Scientific Officer) and Mr Tony Loughman (Senior Product Development Scientist) will be in attendance. A poster entitled “Analytical validation of OncoMasTR, a multigene test for predicting risk of distant recurrence in hormone receptor-positive early stage breast cancer” (Ref 204P) will be presented by Mr Tony Loughman. The poster presentation will be held on Monday 22nd October, with a dedicated viewing from 12:45-13:45.
Please visit this poster to hear more about OncoMasTR and to engage with the OncoMark team.